-
Korea lags behind global standards in kidney cancer treatment, expert warns
19 Jun 2025 09:18 GMT
… tried. Currently, cytotoxic anticancer drugs are only used for a … kidney cancer called collecting duct renal cell carcinoma.
Recently, targeted therapies, including …
Park emphasized that kidney cancer drug treatment has improved significantly, but domestic …
-
Navigating Second-Line RCC Treatment With Guidelines and Trial Data
18 Jun 2025 08:20 GMT
Second-line treatment for clear cell renal cell carcinoma (RCC) remains challenging due to a … me, it's a drug that has significant activity. I … tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor …
-
George Shares Takeaways From IO Trials and AE Management in Pretreated RCC
18 Jun 2025 18:05 GMT
… mitigated with drug holds or other medications.
GEORGE: … lot of other drugs like nivolumab and … renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment … monotherapy in patients with renal cell carcinoma (RCC) following 1 or …
-
KEYNOTE-564: Favorable Long-Term Safety With Adjuvant Pembrolizumab in RCC
18 Jun 2025 18:04 GMT
… of adjuvant pembrolizumab for the treatment of renal cell carcinoma (RCC).
Over the past 3 … earlier recognition and more prompt treatment of these toxicities, an … pembrolizumab (pembro) for the treatment of clear cell renal cell carcinoma (ccRCC). J Clin …
-
GI Innovation wins US patent for dual-action IL-2 therapy targeting cold tumors
19 Jun 2025 07:10 GMT
… exclusive rights to the drug’s bispecific fusion … or cytotoxic lymphocytes.
The drug is designed to revive … NSCLC, pancreatic cancer, and renal cell carcinoma at Severance Hospital, Samsung … combination. Importantly, the treatment did not trigger cytokine …
-
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
19 Jun 2025 05:07 GMT
… s top-selling cancer drug, pembrolizumab (Keytruda; Merck … Inventory management, updating treatment plans, and educating staff … seen this with other drugs,” notably rituximab, Soefje … or metastatic clear cell renal cell carcinoma (ccRCC): pharmacokinetics (PK …
-
Zanzalintinib/Nivolumab Combo Shows Promise in Advanced RCC
14 Jun 2025 16:50 GMT
… with previously untreated stage 4 renal cell carcinoma (RCC). Initial findings from an expansion …
The most common reason for treatment discontinuation was radiographic progression, reported … nivolumab/relatlimab arm. Treatment-emergent AEs of any grade …
-
Dr Chehrazi-Raffle on the Safety of Second-Line Tivozanib With/Without Nivolumab in RCC
14 Jun 2025 06:53 GMT
… ) in patients with metastatic renal cell carcinoma (RCC), as well as clinical … nivolumab as second-line treatment. Findings presented at the … -line setting for metastatic RCC, Chehrazi-Raffle emphasized. … alone in patients with RCC.
In the subgroup analysis …
-
American Kidney Fund Launches Kidney Cancer Education Campaign
18 Jun 2025 13:13 GMT
… adults is renal cell carcinoma (RCC), which is further divided into clear cell renal cell carcinoma (ccRCC … genetic diseases, and long-term treatment for kidney failure. ### About …
-
Zanzalintinib Triplet Combo Under Investigation in Kidney Cancer Subgroups
17 Jun 2025 22:09 GMT
… treatment option worth exploring in patients with previously untreated clear cell renal cell carcinoma … doses or temporarily holding the medications.
One notable part of the … we continue searching for new drugs and regimens for patients with …